Blade Air Mobility is now largely a medical organ-transport business, which could benefit as hospitals need faster, more reliable logistics and new tech helps keep organs viable longer. But the bet also comes with big “what ifs,” from aircraft availability and service costs to whether a next-generation aircraft partnership shows up on time.Read more
Blade Air Mobility is reshaping itself around time-critical medical flights, betting that rising transplant demand and new aircraft technology can make it faster, cheaper, and harder to compete with. The big question is whether that focus and deal-making push turn into a durable edge—or whether regulation, outside operators, and integration slip-ups hold it back.Read more
Blade Air Mobility is betting big on hospital flights like organ transport, where demand keeps rising and long-term hospital relationships can bring steady repeat business. The catch is that narrowing the company down to this one niche and leaning on acquisitions and key partners could make results swing more than investors expect.Read more
No trending discussion available.
Strata Critical Medical, Inc. provides time-critical logistics and medical services to the healthcare industry in the United States. It operates in two segments, Logistics and Clinical. The company offers logistics services, such as air and ground transportation for human organs, transplant teams, and related medical materials and organ placement services; transplant clinical services, including organ recovery procedures, normothermic regional perfusion, and preservation services. It also provides other clinical services comprising cardiac perfusion services, blood management and autotransfusion services, extracorporeal membrane oxygenation services, perfusion staffing, and equipment rentals. The company was formerly known as Blade Air Mobility, Inc. and changed its name to Strata Critical Medical, Inc. in August 2025. The company was founded in 2014 and is headquartered in New York, New York.
